Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects.

The multiple-dose pharmacokinetics of ritonavir were investigated in four groups of human immunodeficiency virus-positive male subjects (with 16 subjects per group) under nonfasting conditions; a 3:1 ritonavir:placebo ratio was used. Ritonavir was given at 200 (group I), 300 (group II), 400 (group I...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Hsu, A, Granneman, G R, Witt, G, Locke, C, Denissen, J, Molla, A, Valdes, J, Smith, J, Erdman, K, Lyons, N, Niu, P, Decourt, J P, Fourtillan, J B, Girault, J, Leonard, J M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1997
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163822/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145841/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.898
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!